Literature DB >> 10680600

Guidelines for surveillance, prevention, and control of West Nile virus infection--United States.

.   

Abstract

The introduction of West Nile (WN) virus in the northeastern United States during the summer and fall of 1999 raised the issue of preparedness of public health agencies to handle sporadic and outbreak-associated vector-borne diseases. In many local and state health departments, vector-borne disease capacity has diminished. Because it is unknown whether the virus can persist over the winter, whether it has already or will spread to new geographic locations, and the public health and animal health implications of this introduction, it is important to establish proactive laboratory-based surveillance and prevention and control programs to limit the impact of the virus in the United States. On November 8 and 9, 1999, CDC and the U.S. Department of Agriculture (USDA) cosponsored a meeting of experts representing a wide range of disciplines to review the outbreak and to provide input and guidance on the programs that should be developed to monitor WN virus activity and to prevent future outbreaks of disease. This report summarizes the guidelines established during this meeting.

Entities:  

Mesh:

Year:  2000        PMID: 10680600

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  15 in total

1.  Comparison of flavivirus universal primer pairs and development of a rapid, highly sensitive heminested reverse transcription-PCR assay for detection of flaviviruses targeted to a conserved region of the NS5 gene sequences.

Authors:  N Scaramozzino; J M Crance; A Jouan; D A DeBriel; F Stoll; D Garin
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

2.  West Nile virus - where did it come from and where might it go?

Authors:  B L Johnston; J M Conly
Journal:  Can J Infect Dis       Date:  2000-07

Review 3.  West Nile virus in the transfusion setting with a special focus on Italian preventive measures adopted in 2008-2012 and their impact on blood safety.

Authors:  Simonetta Pupella; Giulio Pisani; Karen Cristiano; Liviana Catalano; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2013-10-23       Impact factor: 3.443

4.  Flavivirus RNA cap methyltransferase: structure, function, and inhibition.

Authors:  Lihui Liu; Hongping Dong; Hui Chen; Jing Zhang; Hua Ling; Zhong Li; Pei-Yong Shi; Hongmin Li
Journal:  Front Biol (Beijing)       Date:  2010-08-01

Review 5.  West Nile virus--an old virus learning new tricks?

Authors:  Thomas Briese; Kristen A Bernard
Journal:  J Neurovirol       Date:  2005-10       Impact factor: 2.643

6.  Infectious cDNA clone of the epidemic west nile virus from New York City.

Authors:  Pei-Yong Shi; Mark Tilgner; Michael K Lo; Kim A Kent; Kristen A Bernard
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

7.  Efficacy of interferon alpha-2b and ribavirin against West Nile virus in vitro.

Authors:  John F Anderson; James J Rahal
Journal:  Emerg Infect Dis       Date:  2002-01       Impact factor: 6.883

8.  Risk factors for human infection with West Nile Virus in Connecticut: a multi-year analysis.

Authors:  Ann Liu; Vivian Lee; Deron Galusha; Martin D Slade; Maria Diuk-Wasser; Theodore Andreadis; Matthew Scotch; Peter M Rabinowitz
Journal:  Int J Health Geogr       Date:  2009-11-27       Impact factor: 3.918

9.  St. Louis Encephalitis and West Nile Virus Encephalitis.

Authors:  Micheline McCarthy
Journal:  Curr Treat Options Neurol       Date:  2001-09       Impact factor: 3.972

10.  Long-term prognosis for clinical West Nile virus infection.

Authors:  Anne Labowitz Klee; Beth Maidin; Barbara Edwin; Iqbal Poshni; Farzad Mostashari; Annie Fine; Marcelle Layton; Denis Nash
Journal:  Emerg Infect Dis       Date:  2004-08       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.